A young woman presenting with recurrent episodes of uterine bleeding due to an extensive uterine arteriovenous malformation was treated with two sessions of uterine artery embolization. Further bleeding was managed with a combination of gonadotropin-releasing hormone and depot medroxyprogesterone acetate. The patient remains asymptomatic with a significant decrease in uterine and pelvic vascularity at one year follow-up.
These drugs may decrease the need for repeat embolization.
Arteriovenous malformation, uterine artery embolization, gonadotropin-releasing hormone agonist, depot medroxyprogesterone acetate
The authors report no conflict of interest.
Copyright © 2014 Padma Krishnaswamy, Indushekar Subbanna, Gayatri Devi Sivasambu, and Urvashi Thukral
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Krishnaswamy P, Subbanna I, Sivasambu G, Thukral U. Gonadotropin-releasing hormone agonist and depot medroxyprogesterone acetate following uterine artery embolization in the management of uterine arteriovenous malformation. Proc Obstet Gynecol. 2014 Jul 01;4(1):Article 4 [12 p.]. https://doi.org/10.17077/2154-4751.1203. Free full text article.